December 15, 2025

Genetic Testing Uncovers Hidden Cancer Risk

Population screening identifies pathogenic variants in patients who wouldn't qualify under current guidelines

Conexiant

December 09, 2025

How AI Is Ushering in a New Era in Cancer Care

On October 30, 2025, Google Cloud held its second annual Cancer AI Symposium to explore how artificial intelligence (AI) is advancing cancer research, diagnosis, and treatment, in unparalleled ways. H...

The ASCO Post

November 24, 2025

Oral PCSK9 Inhibitor Tied to LDL-C Drop

The oral PCSK9 inhibitor enlicitide decanoate achieved 58% LDL-C reduction in patients with heterozygous familial hypercholesterolemia, offering a potential alternative to injectable therapies.

Conexiant

November 21, 2025

Positive trends in chronic HCV mortality 

“DAAs have revolutionized the management of HCV by making it a curable disease.”

Conexiant

November 21, 2025

Tirzepatide tops semaglutide for cardiometabolic protection in MASLD

The study authors recommend prospective head-to-head trials to validate the findings.

Conexiant

November 20, 2025

New score challenges old predictors

"MERAGE has superior performance for predicting return to drinking (RTD) compared to HRAR in AH."

Conexiant

November 14, 2025

New ddPCR Test Detects Lyme Disease More Accurately

The droplet digital PCR assays, developed at Dartmouth, could improve diagnosis of Lyme disease.

Conexiant

November 13, 2025

Allergies May Increase Surgical Risk

Researchers show that patients with allergies face higher postoperative risks.

Conexiant

November 13, 2025

New AI Model Guides UTI Therapy Decisions

A predictive algorithm presented at AMP 2025 may extend the Guidance UTI workflow by delivering actionable insights before full susceptibility results are available.

Conexiant